Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Edwards Lifesciences Corporation (EW) had Cost of Goods Sold of $343.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.57B |
|
$91.20M |
|
|
Cost of Goods Sold |
$343.00M |
$1.23B |
|
$1.42B |
|
$151.10M |
|
$-60.70M |
|
$90.40M |
|
$190.20M |
|
$64.20M |
|
$64.20M |
|
$91.20M |
|
$192.92M |
|
$151.10M |
|
-- |
|
580.40M |
|
581.80M |
|
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|